Clinical trial

Symptom-driven ICS/LABA Therapy for Adolescent Patients With Asthma Non-adherent to Daily Maintenance Inhalers

NCT05689983

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Maintenance ICS and Symptom Driven SABA Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Symptom-driven budesonide/formoterol combination Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Symptom-driven ICS/LABA Therapy for Adolescent Patients With Asthma Non-adherent to Daily Maintenance Inhalers

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1, PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2022-04-01

PhasePHASE1 / PHASE2

Conditions

Asthma in Childrenunresolved

Nonadherence, Medicationunresolved

Interventions

Maintenance ICS and Symptom Driven SABADRUG

Symptom-driven budesonide/formoterol combinationDRUG

Sponsors & collaborators

Washington University School of Medicinelead sponsor

National Institutes of Health (NIH)collaborator

National Center for Advancing Translational Sciences (NCATS)collaborator

Mapped research locations

St LouisMissouri, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05689983 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.